Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.7.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JQ.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.502NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.285NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.582NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.580NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.306NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.280NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.329NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.396NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.311NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.369NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.367NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.240NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.529 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.41.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.33 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used